Intra-Cellular Therapies Inc (ITCI)
70.97
+2.17
(+3.15%)
USD |
NASDAQ |
May 06, 16:00
70.97
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Total Liabilities (Quarterly): 136.87M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 136.87M |
| September 30, 2023 | 116.98M |
| June 30, 2023 | 106.51M |
| March 31, 2023 | 94.55M |
| December 31, 2022 | 98.71M |
| September 30, 2022 | 96.58M |
| June 30, 2022 | 89.71M |
| March 31, 2022 | 75.83M |
| December 31, 2021 | 72.03M |
| September 30, 2021 | 70.22M |
| June 30, 2021 | 72.11M |
| March 31, 2021 | 62.34M |
| December 31, 2020 | 60.45M |
| September 30, 2020 | 61.90M |
| June 30, 2020 | 61.40M |
| March 31, 2020 | 50.79M |
| December 31, 2019 | 56.18M |
| September 30, 2019 | 53.64M |
| June 30, 2019 | 53.09M |
| March 31, 2019 | 54.36M |
| December 31, 2018 | 39.49M |
| September 30, 2018 | 31.96M |
| Date | Value |
|---|---|
| June 30, 2018 | 21.69M |
| March 31, 2018 | 22.45M |
| December 31, 2017 | 17.05M |
| September 30, 2017 | 14.75M |
| June 30, 2017 | 9.874M |
| March 31, 2017 | 19.27M |
| December 31, 2016 | 13.40M |
| September 30, 2016 | 143.25M |
| June 30, 2016 | 21.64M |
| March 31, 2016 | 10.92M |
| December 31, 2015 | 7.861M |
| September 30, 2015 | 11.27M |
| June 30, 2015 | 9.839M |
| March 31, 2015 | 14.75M |
| December 31, 2014 | 10.56M |
| September 30, 2014 | 3.578M |
| June 30, 2014 | 2.739M |
| March 31, 2014 | 3.912M |
| December 31, 2013 | 6.834M |
| September 30, 2013 | 7.775M |
| June 30, 2013 | 0.033M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.79M
Minimum
Mar 2020
136.87M
Maximum
Dec 2023
78.42M
Average
72.03M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 101.95B |
| Insmed Inc | 1.662B |
| Vertex Pharmaceuticals Inc | 5.150B |
| Fate Therapeutics Inc | 137.80M |
| ADMA Biologics Inc | 193.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 728.30M |
| Shareholders Equity (Quarterly) | 591.42M |
| Current Ratio | 5.405 |